Ensuring diversity of the tissue sources used in preclinical research so that scientists can better understand the full range of human responses to chemicals is one of the biggest scientific challenges US Food and Drug Administration Chief Scientist Namandjé Bumpus faces.
While there’s been a lot of focus in recent years on improving the diversity of clinical research, Bumpus said more...






